Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 6, 2006, Pages 664-672

  Gaertner, J ^a   Radbruch, L ^b   Giesecke, T ^a   Gerbershagen, H ^a   Petzke, F ^a   Ostgathe, C ^a   Elsner, F ^b   Sabatowski, R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cognitive functioning; Driving ability; Non cancer pain; Opioid; Oxycodone; Psychomotor performance

Indexed keywords

NARCOTIC ANALGESIC AGENT; OXYCODONE;

ADULT; AGED; AGING; AROUSAL; ARTICLE; ATTENTION; BIOASSAY; CAR DRIVING; COGNITION; DELAYED RELEASE FORMULATION; DRUG EFFECT; FEMALE; GERMANY; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; AGED; AGING; ANALGESICS, OPIOID; AROUSAL; ATTENTION; AUTOMOBILE DRIVING; COGNITION; DELAYED-ACTION PREPARATIONS; ENDPOINT DETERMINATION; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; OXYCODONE; PSYCHOMOTOR PERFORMANCE;

EID: 33750093307     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01027.x     Document Type: Article

References (49)

1. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000; 19: 16-20. (Pubitemid 30169046)
2. Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998; 15: 168-75. (Pubitemid 28169139)
3. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998; 23: 2591-600. (Pubitemid 29003533)
4. Foley K. Opioids and chronic neuropathic pain. N Engl J Med 2003; 348: 1279-81. (Pubitemid 36359305)
5. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999; 83: 761-86. (Pubitemid 29259146)
6. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage 2000; 19: 100-8. (Pubitemid 30116799)
7. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995; 346: 667-70.
8. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998; 15: 185-94. (Pubitemid 28169141)
9. Hanks GW, O'Neill WM, Simpson P, Wesnes K. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol 1995; 48: 455-60.
10. Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage 2003; 25: 38-47. (Pubitemid 36143650)
11. Tassain V, Attal N, Fletcher D, Brasseur L, Degieux P, Chauvin M et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003; 104: 389-400. (Pubitemid 36835907)
12. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003; 26: 913-21. (Pubitemid 37188468)
13. Clemons M, Regnard C, Appleton T. Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev 1996; 22: 451-68. (Pubitemid 27199236)
14. Hanks GW. Morphine sans morpheus. Lancet 1995; 346: 652-3.
15. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992; 7: 69-77.
16. Galski T, Williams JB, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage 2000; 19: 200-8. (Pubitemid 30173234)
17. Strumpf M, Köhler A, Zenz M, Willweber-Strumpf A, Dertwinkel R, Donner B. Opioids and driving ability. Schmerz 1997; 11: 233-40. (Pubitemid 27400399)
18. Davis MP, Varga J, Dickerson D, Walsh D, LeGrand SB, Lagman R. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer 2003; 11: 84-92. (Pubitemid 36733817)
19. Rosenberg D. Oxy's offspring. Newsweek 2002; 139: 37.
20. Schwabe U, Paffrath D. Arzneiverordnungs-Report 2002. Berlin: Springer, 2003.
21. Bundesanstalt für Straßenwesen. Begutachtungs-Leitlinien zur Kraftfahrereignung. Bergisch Gladbach: Wirtschaftsverlag NW, 2000.
22. International Council on Alcohol Drugs and Traffic Safety (ICADTS). Guidelines on Experimental Studies Undertaken to Determine a Medicinal Drug's Effect on Driving or Skills Related to Driving. Ontario: ICADTS, 1999.
23. Herberg K. Untersuchung der Entwicklung der sicherheitsrelevanten Leistungsfähigkeit mit dem Lebensalter, 2nd edn. Cologne: TÜV Kraftfahrt Gmbh - Institut für Verkehrssicherheit, 1998.
24. Kroj G. Psychologisches Gutachten Kraftfahreignung. Bonn: Deutscher Psychologenverlag, 1995.
25. Kroj G. Perspektiven für Forschung und Begutachtung aus psychologischer Sicht. In: Bundesanstalt für Straßenwesen, ed. Drogen und Verkehrssicherheit . Bergisch Gladbach: Wirtschaftsverlag NW, 1995: 78-82.
26. Hilgers R, Friedel B, Berghaus G. Äquivalenztestung im Rahmen experimenteller Untersuchungen zur Fahrtüchtigkeit. In: Bundesanstalt für Straßenwesen, ed. Kongreßbericht 1997 der Deutschen Gesellschaft für Verkehrsmedizin e.V. Bergisch Gladbach: Wirtschaftsverlag NW, 1998: 130-4.
27. Herberg KW. Age-related changes in aspects of performance relevant to safety. Eur J Ger 2000; 2: 18-26.
28. Bundesregierung Deutschland. Verordnung über die Zulassung von Personen zum Straßenverkehr und zur Änderung straß enverkehrsrechtlicher Vorschriften. Bundesgesetzblatt 1998; 55: 2214-2306.
29. Schuhfried GmbH. Cognitrone - Handbuch. Mödling: Dr. Schuhfried GmbH, 1994.
30. Schuhfried GmbH. Wiener Determinationstest, Version 2.00. Mödling: Dr. Schuhfried GmbH, 1996.
31. Schuhfried GmbH. Zweihand-Koordination, Version 4.00. Mödling: Dr. Schuhfried GmbH, 1995.
32. Schuhfried GmbH. Vigilanz, Version 5.00. Mödling: Dr. Schuhfried GmbH, 1995.
33. Thapar P, Zacny JP, Thompson W, Apfelbaum JL. Using alcohol as a standard to assess the degree of impairment induced by sedative and analgesic drugs used in ambulatory surgery. Anesthesiology 1995; 82: 53-9.
34. Richter R, Hobi V. The impairment of the ability to drive with blood alcohol concentrations of 0.5 per milliliter. A review of the literature. Schweiz Med Wochenschr 1975; 105: 884-90.
35. Bartl G, Lager F, Domesle L. Test performance with minimal alcoholic intoxication. Blutalkohol 1996; 33: 1-16. (Pubitemid 26040058)
36. Herberg KW. Antidepressives and traffic safety. Fortschr Neurol Psychiatr 1994; 1: 24-8.
37. O'Brien P. Procedures for Comparing Samples with Multiple Endpoints. Biometrics 1984; 40: 1079-87.
38. World Health Organization (WHO). Cancer Pain Relieve with a Guide to Opioid Availability. Geneva: WHO, 1996.
39. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76.
40. Hanks GW, Conno F, Cherny N et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001; 84: 587-93. (Pubitemid 32238990)
41. Zacny JP, Lichtor JL, Thapar P, Coalson DW, Flemming D, Thompson WK. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther 1994; 270: 579-88. (Pubitemid 24271369)
42. Walker DJ, Zacny JP. Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl) 1998; 140: 191-201. (Pubitemid 28538479)
43. Schneider U, Bevilacqua C, Jacobs R et al. Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects. Neuropsychobiology 1999; 39: 38-43. (Pubitemid 29037763)
44. Zacny JP, Lichtor JL, Zaragoza JG, de Wit H. Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology (Berl) 1992; 107: 319-26.
45. Veselis RA, Reinsel RA, Feshchenko VA et al. Impaired memory and behavioral performance with fentanyl at low plasma concentrations. Anesth Analg 1994; 79: 952-60. (Pubitemid 24324677)
46. Menefee LA, Frank ED, Crerand C, et al.The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med 2004; 5: 42-9. (Pubitemid 38404443)
47. Kuhajda M, Thorn B, Klinger M, Rubin N. The effect of headache pain on attention (encoding) and memory (recognition). Pain 2002; 97: 213-21. (Pubitemid 34614537)
48. Lorenz J, Beck H, Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 1997; 73: 369-75. (Pubitemid 28021841)
49. Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 2005; 117: 388-95. (Pubitemid 41383533)